Abramson Cancer Center of University of Pennsylvania

Philadelphia, Pennsylvania 19104

0 studies enrolling now · 5 studies all time

What they study most

AML, Acute Myeloid Leukemia, Breast Cancer, Myeloma, Non-Small Cell Lung Cancer

Studies at this site

• Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia — Stopped early
• Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV NSCLC — Completed
• Study of Bexarotene in Patients With Acute Myeloid Leukemia — Completed
• Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy — Withdrawn before enrolling
• Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma — Stopped early